- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Syndax Pharmaceuticals Inc (1T3)Syndax Pharmaceuticals Inc stock price live, this page displays NASDAQ SNDX stock exchange data. View the SNDX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Syndax Pharmaceuticals Inc real time stock price chart below.
What Is the Syndax Pharmaceuticals Inc Stock Price Today?
The Syndax Pharmaceuticals Inc stock price today is 15.4000.
What Is the Stock Symbol for Syndax Pharmaceuticals Inc?
The stock symbol for Syndax Pharmaceuticals Inc is "SNDX."
What Stock Exchange Does Syndax Pharmaceuticals Inc Trade On?
Syndax Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Syndax Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Syndax Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SNDX quote. (ISIN: US87164F1057)
What Is the Syndax Pharmaceuticals Inc Stock Price Today?
The Syndax Pharmaceuticals Inc stock price today is 15.4000.
What Is the Stock Symbol for Syndax Pharmaceuticals Inc?
The stock symbol for Syndax Pharmaceuticals Inc is "SNDX."
What Stock Exchange Does Syndax Pharmaceuticals Inc Trade On?
Syndax Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Syndax Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Syndax Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SNDX quote. (ISIN: US87164F1057)
15.4000
-0.2000(-1.28%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.4000
15.4000
52 wk Range
14.3000
22.2000
1T3 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.400015.4000
52 wk Range
14.300022.2000
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
Unlock1T3 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
36.6900
Upside
+120.7581%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Syndax Pharmaceuticals Inc Company Profile
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are revumenib, a potent, selective, small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged, acute leukemias, and solid tumor; and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD) and idiopathic pulmonary fibrosis (IPF). The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.
Compare 1T3 to Peers and Sector
Metrics to compare | 1T3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1T3PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.8x | −0.9x | −0.7x | |
PEG Ratio | 0.12 | 0.06 | 0.00 | |
Price/Book | 3.9x | 1.0x | 2.6x | |
Price / LTM Sales | 88.7x | 24.6x | 3.2x | |
Upside (Analyst Target) | - | 331.0% | 46.4% | |
Fair Value Upside | Unlock | 6.1% | 6.9% | Unlock |
People Also Watch
FAQ
What Is the Syndax Pharmaceuticals (1T3) Stock Price Today?
The Syndax Pharmaceuticals stock price today is 15.40
What Stock Exchange Does Syndax Pharmaceuticals Trade On?
Syndax Pharmaceuticals is listed and trades on the Frankfurt stock exchange.
What Is the Stock Symbol for Syndax Pharmaceuticals?
The stock symbol for Syndax Pharmaceuticals is "1T3."
What Is the Syndax Pharmaceuticals Market Cap?
As of today, Syndax Pharmaceuticals market cap is 1.35B.
What is Syndax Pharmaceuticals Earnings Per Share?
The Syndax Pharmaceuticals EPS is -3.62.
From a Technical Analysis Perspective, Is 1T3 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.